Percutaneous Dose Of CD34-Positive Cells May Ease Ischemia, Improve Symptoms In Coronary Microvascular Dysfunction, Research Suggests https://www.medpagetoday.com/meetingcoverage/scai/86500 #COVID19 #cardiotwitter #echofirst